Advances in Continuous Glucose Monitoring: Clinical Applications
Endocrinology and Metabolism · 30.04.2025 · 40 (2) · 161-173
DOI: 10.3803/enm.2025.2370 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, erschienen am 30.04.2025. Verfasst von So Yoon Kwon und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Korea. Hauptthemen laut MEDLINE: Blood Glucose Self-Monitoring, Blood Glucose, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.
Abstract (Originalsprache)
Continuous glucose monitoring (CGM) has revolutionized diabetes management, significantly enhancing glycemic control across diverse patient populations. Recent evidence supports its effectiveness in both type 1 and type 2 diabetes management, with benefits extending beyond traditional glucose monitoring approaches. CGM has demonstrated substantial improvements in glycemic control across multiple metrics. Studies report consistent glycosylated hemoglobin reductions of 0.25%–3.0% and notable time in range improvements of 15%–34%. CGM effectively reduces hypoglycemic events, with studies reporting significant reductions in time spent in hypoglycemia. CGM also serves as an educational tool for lifestyle modification, providing real-time feedback that helps patients understand how diet and physical activity affect glucose levels. While skin-related complications remain a concern, technological advancements have addressed many initial concerns. High satisfaction rates and long-term use suggest that device-related issues are manageable with proper education and support. Despite high initial costs, CGM’s prevention of complications and hospitalizations ultimately reduces healthcare expenditures. With appropriate training and support, CGM represents a transformative technology for comprehensive diabetes care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Korea.
- Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea.
Förderung
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
Zitieren
APA
Kwon, S. Y., & Moon, J. S. (2025). Advances in Continuous Glucose Monitoring: Clinical Applications. Endocrinology and Metabolism, 40(2), 161-173. https://doi.org/10.3803/enm.2025.2370
Vancouver
Kwon SY, Moon JS. Advances in Continuous Glucose Monitoring: Clinical Applications. Endocrinology and Metabolism. 2025;40(2):161-173. doi:10.3803/enm.2025.2370
BibTeX
@article{Kwon2025,
author = {Kwon, So Yoon and Moon, Jun Sung},
title = {Advances in Continuous Glucose Monitoring: Clinical Applications},
journal = {Endocrinology and Metabolism},
year = {2025},
volume = {40},
number = {2},
pages = {161--173},
doi = {10.3803/enm.2025.2370}
}
EUVIMED